View in EDS

Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility.

Saved in:
Bibliographic Details
Title: Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility.
Authors: Merz LE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Department of Medicine, Mass General Brigham, Boston, Massachusetts., Wang Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Cronin A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Sharon E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Walsh TP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hibbs SP; Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom., Lathan CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hantel A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts.
Source: JAMA oncology [JAMA Oncol] 2025 Dec 01; Vol. 11 (12), pp. 1540-1542.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41066103
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Merz+LE%22">Merz LE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Department of Medicine, Mass General Brigham, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Cronin+A%22">Cronin A</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sharon+E%22">Sharon E</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Walsh+TP%22">Walsh TP</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hibbs+SP%22">Hibbs SP</searchLink>; Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lathan+CS%22">Lathan CS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hantel+A%22">Hantel A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Bioethics, Harvard Medical School, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2025 Dec 01; Vol. 11 (12), pp. 1540-1542.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41066103
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaoncol.2025.3869
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1540
    Titles:
      – TitleFull: Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Merz LE
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Cronin A
      – PersonEntity:
          Name:
            NameFull: Sharon E
      – PersonEntity:
          Name:
            NameFull: Walsh TP
      – PersonEntity:
          Name:
            NameFull: Hibbs SP
      – PersonEntity:
          Name:
            NameFull: Lathan CS
      – PersonEntity:
          Name:
            NameFull: Hantel A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2374-2445
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: JAMA oncology
              Type: main
ResultId 1